Legal status (US): Tesamorelin is FDA-approved under the brand names Egrifta and Egrifta WR, manufactured by Theratechnologies, specifically to reduce excess visceral abdominal fat in HIV-infected patients with lipodystrophy
Rather than reconstituting everything simultaneously, prepare each peptide as needed to maximize individual stability windows
Merriam GR, Kletke M, Barsness S, Buchner D, Hirth V, Moe KE, Schwartz RS, Vitiello MV
You can read more about the trial here: Setria glutathione has also been shown to have a unique stability against stomach acid, making it impressively bioavailable
This microbial suppression complements the chemical stability benefits of cold storage